Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash & Current Investments (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Cash & Current Investments for 16 consecutive years, with $30.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 6.32% to $30.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.5 million through Dec 2025, up 6.32% year-over-year, with the annual reading at $29.1 million for FY2025, 3.45% down from the prior year.
  • Cash & Current Investments hit $30.5 million in Q4 2025 for Mesa Laboratories, up from $21.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $278.3 million in Q3 2021 to a low of $21.9 million in Q3 2025.
  • Historically, Cash & Current Investments has averaged $69.1 million across 5 years, with a median of $32.1 million in 2023.
  • Biggest five-year swings in Cash & Current Investments: surged 224.24% in 2021 and later plummeted 87.36% in 2022.
  • Year by year, Cash & Current Investments stood at $51.7 million in 2021, then plummeted by 46.23% to $27.8 million in 2022, then increased by 9.22% to $30.4 million in 2023, then fell by 5.62% to $28.7 million in 2024, then increased by 6.32% to $30.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for MLAB at $30.5 million in Q4 2025, $21.9 million in Q3 2025, and $23.0 million in Q2 2025.